Anzahl der Publikationen: 11
Zeitschriftenartikel
Zhang, Danmei; Ebrahim, Mariam; Adler, Kristin; Blanchet, Xavier; Jamasbi, Janina; Megens, Remco T. A.; Uhland, Kerstin; Ungerer, Martin; Muench, Goetz; Deckmyn, Hans; Weber, Christian; Elia, Natalie; Lorenz, Reinhard und Siess, Wolfgang
(2020):
Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood.
In: Thrombosis and Haemostasis, Bd. 120, Nr. 6: S. 977-993
Goldmann, Luise; Duan, Rundan; Kragh, Thorsten; Wittmann, Georg; Weber, Christian; Lorenz, Reinhard; Hundelshausen, Philipp von; Spannagl, Michael und Siess, Wolfgang
(2019):
Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (Fc gamma RIIA): a new option in HIT?
In: Blood Advances, Bd. 3, Nr. 23: S. 4021-4033
Denzinger, Viola; Busygina, Kristina; Jamasbi, Janina; Pekrul, Isabell; Spannagl, Michael; Weber, Christian; Lorenz, Reinhard und Siess, Wolfgang
(2019):
Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.
In: Thrombosis and Haemostasis, Bd. 119, Nr. 3: S. 397-406
Ebrahim, Mariam; Jamasbi, Janina; Adler, Kristin; Megens, Remco T. A.; M'Bengue, Yacine; Blanchet, Xavier; Uhland, Kerstin; Ungerer, Martin; Brandl, Richard; Weber, Christian; Elia, Natalie; Lorenz, Reinhard; Münch, Götz und Siess, Wolfgang
(2018):
Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
In: Thrombosis and Haemostasis, Bd. 118, Nr. 2: S. 351-361
Busygina, Kristina; Jamasbi, Janina; Seiler, Till; Deckmyn, Hans; Weber, Christian; Brandl, Richard; Lorenz, Reinhard und Siess, Wolfgang
(2018):
Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans.
In: Blood, Bd. 131, Nr. 24: S. 2605-2616
Munoz, Ann-Katrin Mojica; Jamasbi, Janina; Uhland, Kerstin; Degen, Heidrun; Münch, Götz; Ungerer, Martin; Brandl, Richard; Megens, Remco; Weber, Christian; Lorenz, Reinhard und Siess, Wolfgang
(2017):
Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
In: Thrombosis and Haemostasis, Bd. 117, Nr. 8: S. 1651-1659
Degen, Heidrun; Borst, Oliver; Ziegler, Melanie; Munoz, Ann-Katrin Mojica; Jamasbi, Janina; Walker, Britta; Göbel, Silvia; Fassbender, Julia; Adler, Kristin; Brandl, Richard; Mönch, Götz; Lorenz, Reinhard; Siess, Wolfgang; Gawaz, Meinrad und Ungerer, Martin
(2017):
ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
In: Journal of the American Heart Association, Bd. 6, Nr. 8, e005991
Diese Liste wurde am
Sat Nov 23 18:24:44 2024 CET
erstellt.